ScienceSlides in published works

ScienceSlides has been frequently used in print. Below is a partial list of publications that feature graphical aids created with the help of ScienceSlides.

  • Sonja Dragojevic, Jung Su Ryu and Drazen Raucher; Polymer-Based Prodrugs: Improving Tumor Targeting and the Solubility of Small Molecule Drugs in Cancer Therapy. Molecules 2015, 20 (12), 21750-21769;
  • Xue P, Fu J, Zhou Y; The Aryl Hydrocarbon Receptor and Tumor Immunity. Front. Immunol. 2018 Feb 13; 9:286. 2018.
  • Meng Z, Moroishi T, Guan KL. Mechanisms of Hippo pathway regulation. Genes Dev. 2016 Jan 1;30(1):1-17
  • Yi M, Junjun Li, Shengnan Chen, Jing Cai et al. Emerging role of lipid metabolism alterations in Cancer stem cells. J Exp Clin Cancer Res. 2018 Jun 15;37(1)
  • Levi A. Garraway and Eric S. Lander; Lessons from the Cancer Genome. Cell 153, 2013
  • Zhang Q, Claret FX; Phosphatases: the new brakes for cancer development? Enzyme Res 2012;2012:659649
  • S Spiegel, S Milstien and S Grant; Endogenous modulators and pharmacological inhibitors of histone deacetylases in cancer therapy Oncogene 2012 31: 537-551
  • Ertel A, Tsirigos A, Whitaker-Menezes D, Birbe RC, Pavlides S, Martinez-Outschoorn UE, Pestell RG, Howell A, Sotgia F, Lisanti MP; Is cancer a metabolic rebellion against host aging? In the quest for immortality, tumor cells try to save themselves by boosting mitochondrial metabolism. Cell Cycle 2012;11:253-63
  • Tu Q, Zhang J, Dong LQ, Saunders E, Luo E, Tang J, Chen J; Adiponectin inhibits osteoclastogenesis and bone resorption via APPL1-mediated suppression of Akt1. J Biol Chem 2011;286(14):12542-53
  • Stützer I, Esterházy D, Stoffel M; The pancreatic beta cell surface proteome. Diabetologia 2012;55:1877-89
  • Cheung LW, Hennessy BT, Li J, Yu S, Myers AP, Djordjevic B, Lu Y, Stemke-Hale K, Dyer MD, Zhang F, Ju Z, Cantley LC, Scherer SE, Liang H, Lu KH, Broaddus RR, Mills GB; High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism for regulation of PTEN protein stability. Cancer Discov. 2011;1:170-85
  • Lamont KR, Tindall DJ; Minireview: Alternative activation pathways for the androgen receptor in prostate cancer. Mol Endocrinol. 2011;25:897-907
  • Yuan SY, Rigor RR.; Regulation of Endothelial Barrier Function. San Rafael (CA), Morgan & Claypool Life Sciences; 2010
  • Rye, K-A., C. A. Bursill, G. Lambert, F.Tabet, and P. J. Barter; The metabolism and anti-atherogenic properties of HDL. J. Lipid Res. 2009. 50: S195-S200
  • Smart EJ, Xiang-An Li; Hyperglycemia: Cell death in a cave. Biochimica et Biophysica Acta 1772 (2007) 524-526
  • Pearson HA, Peers C; Physiological roles for amyloid beta peptides. J Physiol 2006;575(Pt 1):5-10
  • P Rizzo, C Osipo, K Foreman, T Golde, B Osborne and L Miele; Rational targeting of Notch signaling in cancer. Oncogene 2008; 27, 5124-5131
  • Johnson EL, Singh R, Johnson-Holiday CM, Grizzle WE, Partridge EE, Lillard JW Jr, Singh S; CCR9 interactions support ovarian cancer cell survival and resistance to cisplatin-induced apoptosis in a PI3K-dependent and FAK-independent fashion. J Ovarian Res. 2010; 3:15
  • Davidson G and Niehrs Christof; Emerging links between CDK cell cycle regulators and Wnt signaling. Trends in Cell Biol 2010; 20, 453-460
  • Alain Chariot; The NF-kB-independent functions of IKK subunits in immunity and cancer. Trends in Cell Biology 2009; 19, 404-413
  • Milne SB, Ivanova PT, Armstrong MD, Myers DS, Lubarda J, Shulga YV, Topham MK, Brown HA, Epand RM; Dramatic differences in the roles in lipid metabolism of two isoforms of diacylglycerol kinase. Biochemistry 2008; 47:9372-9
  • Zhong-Jun Wu1, 3, Yu Zhu, De-Rong Huang, and Zhi-Qiang Wang; Constructing the HBV-Human Protein Interaction Network to Understand the Relationship Between HBV and Hepatocellular Carcinoma. J Exp & Clin Cancer Res 2010; 29:146
  • Zhang J, Patel JM; Role of the CX3CL1-CX3CR1 axis in chronic inflammatory lung diseases. Int J Clin Exp Med. 2010; 3:233-44
  • Yang XC, Burch BD, Yan Y, Marzluff WF, Dominski Z.; FLASH, a proapoptotic protein involved in activation of caspase-8, is essential for 3' end processing of histone pre-mRNAs. Mol Cell 2009; 36:267-78.
  • R Kang, HJ Zeh, MT Lotze and D Tang; The Beclin 1 network regulates autophagy and apoptosis Cell Death and Differentiation 2011; 18, 571-580
  • WKK Wu, CW Lee, CH Cho, D Fan, K Wu, J Yu1 and JJY Sung; MicroRNA dysregulation in gastric cancer: a new player enters the game. Oncogene 2010; 29, 5761-5771
  • Dominski Z, Marzluff WF. Formation of the 3' end of histone mRNA: getting closer to the end. Gene 2007; 396:373-90
  • Khan, Farah D; Roychowdhury, Sanjoy; Gaspari, Anthony A; Svensson, Craig K; Immune response to xenobiotics in the skin: from contact sensitivity to drug allergy. Expert Opinion on Drug Metabolism and Toxicology, Volume 2, Number 2, 1 April 2006, pp. 261-272(12)
  • Bruce D. Sidell and Kristin M. O'Brien; When bad things happen to good fish: the loss of hemoglobin and myoglobin expression in Antarctic icefishes J Exp Biol 2006; 209, 1791-1802
  • Z. Dominski, X. Yang, W. Marzluff; The Polyadenylation Factor CPSF-73 Is Involved in Histone-Pre-mRNA Processing. Cell 2005; 123, 37-44
  • Robert Z Orlowski & Erik L Zeger; Targeting the proteasome as a therapeutic strategy against haematological malignancies. Expert Opinion on Investigational Drugs 2006;15,117-130
  • E Claire Dees & Robert Z Orlowski ; Targeting the ubiquitin-proteasome pathway in breast cancer therapy. Future Oncology 2006; 2,121-135
  • Peter M. Voorhees and Robert Z. Orlowski; The proteasome and proteasome inhibitors in cancer therapy. Annual Review of Pharmacology and Toxicology 2006; 46: 189-213

ScienceSlides

  • Content - Browse the fields that ScienceSlides covers
  • Testimonials - Read what people are saying about ScienceSlides
  • Publications - Sample of journal articles which feature ScienceSlides objects are listed